<DOC>
	<DOCNO>NCT01816139</DOCNO>
	<brief_summary>The primary objective study compare efficacy WC3011 placebo vaginal gel postmenopausal woman relief vaginal dryness cause vaginal atrophy measure self-assessment , vaginal pH vaginal smear .</brief_summary>
	<brief_title>Multicenter Study Evaluate Safety Efficacy WC3011 Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Signed informed consent Moderate severe vaginal dryness Postmenopausal meet one following : 12 month spontaneous amenorrhea , 6 month spontaneous amenorrhea serum FSH ( follicle stimulate hormone ) &gt; 40 mIU ( milliInternational Unit ) /mL , 6 week postsurgical bilateral oophorectomy confirm surgical report , ultrasound serum FSH &gt; 40 mIU/mL , 6 week postsurgical hysterectomy ovary failure confirm serum FSH &gt; 40 mIU/mL Age ≥ 40 year bilateral oophorectomy ≥ 35 year Normal breast exam ; &gt; 40 year , documentation negative mammogram Randomization PR04409 , participation clinical trial use investigational drug within 30 day prior screen Smokes ≥ 15 cigarettes/day Known suspect premalignant malignant disease Cardiovascular disease , insulindependent diabetes mellitus , congestive heart failure , stroke ischemic attack , thrombophlebitis thromboembolic disorder Increased frequency/severity headache estrogen therapy Drug addiction/alcohol abuse within last 2 year Currently take St. John 's Wort anticoagulant Uncontrolled hypertension thyroid disorder , clinically significant depression untreated urinary tract infection</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>vaginal dryness</keyword>
	<keyword>vaginal atrophy</keyword>
	<keyword>estrogen</keyword>
</DOC>